CTI BioPharma Corp. (CTIC) Reaches $4.90 After 9.00% Up Move; Sprague Resources LP (SRLP) Sentiment Is 1.18

May 19, 2018 - By Kurt Siggers

Sprague Resources LP (NYSE:SRLP) Logo

The stock of CTI BioPharma Corp. (NASDAQ:CTIC) is a huge mover today! The stock increased 6.29% or $0.29 during the last trading session, reaching $4.9. About 709,959 shares traded or 134.83% up from the average. CTI BioPharma Corp. (NASDAQ:CTIC) has declined 7.09% since May 19, 2017 and is downtrending. It has underperformed by 18.64% the S&P500.The move comes after 8 months positive chart setup for the $284.11M company. It was reported on May, 19 by Barchart.com. We have $5.34 PT which if reached, will make NASDAQ:CTIC worth $25.57M more.

Sprague Resources LP (SRLP) investors sentiment increased to 1.18 in 2017 Q4. It’s up 0.29, from 0.89 in 2017Q3. The ratio is better, as 13 institutional investors started new and increased positions, while 11 sold and trimmed holdings in Sprague Resources LP. The institutional investors in our database now own: 4.85 million shares, down from 5.00 million shares in 2017Q3. Also, the number of institutional investors holding Sprague Resources LP in top ten positions was flat from 0 to 0 for the same number . Sold All: 3 Reduced: 8 Increased: 9 New Position: 4.

Analysts await CTI BioPharma Corp. (NASDAQ:CTIC) to report earnings on August, 2. They expect $-0.25 earnings per share, down 933.33% or $0.28 from last year’s $0.03 per share. After $-0.08 actual earnings per share reported by CTI BioPharma Corp. for the previous quarter, Wall Street now forecasts 212.50% negative EPS growth.

Among 5 analysts covering CTI BioPharma Corp (NASDAQ:CTIC), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. CTI BioPharma Corp had 6 analyst reports since August 15, 2015 according to SRatingsIntel. The stock has “Buy” rating by Roth Capital on Saturday, August 15. The firm has “Hold” rating given on Monday, November 9 by WallachBeth Capital. The firm earned “Buy” rating on Monday, March 26 by Needham.

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. The company has market cap of $284.11 million. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma in the European Union. It currently has negative earnings. The firm is also developing Pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R, which is in Phase Phase III clinical trials for the treatment of myelofibrosis.

More news for CTI BioPharma Corp. (NASDAQ:CTIC) were recently published by: Benzinga.com, which released: “Benzinga’s Daily Biotech Pulse: AstraZeneca’s Q1, Novartis-Amgen Migraine Drug Approved” on May 18, 2018. Seekingalpha.com‘s article titled: “CTI BioPharma’s (CTIC) CEO Adam Craig on Q1 2018 Results – Earnings Call Transcript” and published on May 04, 2018 is yet another important article.

Doheny Asset Management Ca holds 1.79% of its portfolio in Sprague Resources LP for 158,550 shares. Spirit Of America Management Corp Ny owns 220,282 shares or 0.59% of their US portfolio. Moreover, Kayne Anderson Capital Advisors Lp has 0.26% invested in the company for 829,054 shares. The Minnesota-based Advantus Capital Management Inc has invested 0.04% in the stock. Gsa Capital Partners Llp, a United Kingdom-based fund reported 22,517 shares.

More important recent Sprague Resources LP (NYSE:SRLP) news were published by: Globenewswire.com which released: “Sprague Resources LP Announces Chief Accounting Officer Retirement and Appointment” on May 15, 2018, also Globenewswire.com published article titled: “Sprague Resources LP Reports First Quarter 2018 Results”, Seekingalpha.com published: “Sprague Resources’ (SRLP) CEO David Glendon on Q1 2018 Results – Earnings Call Transcript” on May 12, 2018. More interesting news about Sprague Resources LP (NYSE:SRLP) was released by: Globenewswire.com and their article: “Sprague Resources LP Announces a revised record date and payment date for the Cash Distribution of the First …” with publication date: May 02, 2018.

Sprague Resources LP engages in the purchase, storage, distribution, and sale of refined petroleum products and natural gas in the United States. The company has market cap of $526.14 million. The firm operates through four divisions: Refined Products, Natural Gas, Materials Handling, and Other Operations. It has a 20.49 P/E ratio. The Refined Products segment purchases and sells various refined products, such as heating oil, diesel fuel, residual fuel oil, kerosene, jet fuel, gasoline, and asphalt to wholesale and commercial customers.

The stock decreased 0.86% or $0.2 during the last trading session, reaching $23.15. About 34,590 shares traded. Sprague Resources LP (SRLP) has declined 11.28% since May 19, 2017 and is downtrending. It has underperformed by 22.83% the S&P500.

Analysts await Sprague Resources LP (NYSE:SRLP) to report earnings on August, 8. They expect $-0.52 earnings per share, down 33.33% or $0.13 from last year’s $-0.39 per share. After $3.21 actual earnings per share reported by Sprague Resources LP for the previous quarter, Wall Street now forecasts -116.20% negative EPS growth.

Sprague Resources LP (NYSE:SRLP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts